Affiliation: Centers for Disease Control and Prevention
- Values for preventing influenza-related morbidity and vaccine adverse events in childrenLisa A Prosser
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave, 6th Floor, Boston, MA, USA
Health Qual Life Outcomes 3:18. 2005....
- Prioritization of pandemic influenza vaccine: rationale and strategy for decision makingBenjamin Schwartz
National Vaccine Program Office, US Department of Health and Human Services, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop E 05, Atlanta, GA 30333, USA
Curr Top Microbiol Immunol 333:495-507. 2009..This chapter reviews information on influenza vaccine production capacity, describes approaches used in the USA to set priorities for vaccination in the setting of limited supply, and presents a proposed strategy for prioritization...
- Universal influenza vaccination in the United States: are we ready? Report of a meetingBenjamin Schwartz
National Vaccine Program Office, Department of Health and Human Services, Washington, DC, USA
J Infect Dis 194:S147-54. 2006....
- Mass vaccination for annual and pandemic influenzaB Schwartz
Immunization Services Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Curr Top Microbiol Immunol 304:131-52. 2006..Exercising vaccination clinics is important for preparedness and can be done in the context of annual influenza vaccination...
- Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: the case for judicious antimicrobial useB Schwartz
Respiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 28:211-3. 1999..Several studies currently under way will evaluate the impact of intervention on antibiotic use practices and resistant carriage or infection...
- Vaccination policies and programs: the federal government's role in making the system workB Schwartz
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Prim Care 28:697-711, v. 2001..Using examples of newly recommended vaccines, this article describes the infrastructure that underlies a safe and effective program and highlights some of the opportunities and threats likely to impact the system in coming years...
- Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United StatesS E Reef
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
Clin Infect Dis 31:85-95. 2000..Further studies of methods are needed to identify high-risk populations and geographic areas for rubella and CRS and to enhance identification of infants with CRS...
- Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African RepublicA K Rowe
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Pediatr Infect Dis J 19:438-44. 2000..Secondary purposes of the survey were to identify risk factors associated with carriage of a resistant isolate and to compare the survey methods of including only children with pneumonia vs. including all ill children...
- Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995B Beall
Childhood and Respiratory Diseases Branch, Centers for Diseases Control and Prevention, Atlanta, Georgia 30333, USA
J Clin Microbiol 35:1231-5. 1997....
- Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working GroupS F Dowell
Respiratory Diseases Branch, Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
Pediatr Infect Dis J 18:1-9. 1999..vary by geographic region? (4) Where can clinicians learn about resistance patterns in their patient populations? (5) What modifications to laboratory surveillance would improve the utility of the information for clinicians treating AOM?..
- emm typing and validation of provisional M types for group A streptococciR Facklam
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 5:247-53. 1999....
- Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamineD R Feikin
Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 181:1501-5. 2000..7% at the 4-week follow-up. Expanding use of sulfadoxine/pyrimethamine to treat chloroquine-resistant malaria may have implications for national pneumonia programs in developing countries where cotrimoxazole is widely used...
- Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studiesK L O'Brien
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
J Clin Microbiol 39:1021-4. 2001..Recovery of pneumococci after storage of NP material in STGG medium at -70 degrees C is at least as good as that from direct plating. Storage at -20 degrees C is also acceptable. Storage at 4 degrees C for 5 days is not ideal...
- The effect of a community intervention trial on parental knowledge and awareness of antibiotic resistance and appropriate antibiotic use in childrenM J Trepka
Epidemic Intelligence Service, State Branch, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Pediatrics 107:E6. 2001..Overuse of antibiotics for children's upper respiratory infections is widespread and contributes to the emergence of antibiotic-resistant bacteria...
- Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study GroupW L Straus
Centers for Disease Control and Prevention, Public Health Service, Department of Health and Human Services, Atlanta, USA
Lancet 352:270-4. 1998..We studied the effectiveness of co-trimoxazole compared with that of amoxycillin in pneumonia therapy, and assessed the clinical impact of co-trimoxazole resistance...
- Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infectionK L O'Brien
Respiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Clin Infect Dis 30:784-9. 2000..Prevention of pneumococcal disease should be included among the potential benefits of influenza vaccination...
- Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmissionB A Perkins
Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Bull World Health Organ 75:33-42. 1997..This study provides important technical validation of the IMCI algorithm, but the performance of health workers should be monitored during the early part of their IMCI training...
- Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000N Daneman
University of Toronto, Toronto, Ontario, Canada
Clin Infect Dis 41:334-42. 2005..A significant proportion of invasive group A streptococcal infections are hospital acquired. No large, prospective studies have characterized this subgroup of cases and evaluated the risk of transmission in hospitals...